Table 3.
Descriptive analysis of preference for HPV vaccine type and vaccination strategy to vaccinate their children among parents of children aged 9–15 in Guangdong province, China, 2022.
| Total |
Children’s Age |
P-value | |||
|---|---|---|---|---|---|
| 9–12 | 13–14 | 15 | |||
| Parents’ preference for | Frequency (%) | ||||
| HPV vaccine type | 0.001 | ||||
| Bivalent | 193(7.4) | 153(8.1) | 26(5.2) | 14(6.2) | |
| Quadrivalent | 210(8.1) | 158(8.4) | 38(7.5) | 14(6.2) | |
| Nine-valent | 1,772(67.9) | 1,291(68.6) | 337(66.9) | 144(64.0) | |
| No preference | 435(16.7) | 279(14.8) | 103(20.4) | 53(23.6) | |
| HPV vaccination strategy | 0.032 | ||||
| Free domestic bivalent vaccine | 1,025(39.3) | 749(39.8) | 208(41.3) | 68(30.2) | |
| Fixed subsidy with free choices of vaccine type | 1,516(58.1) | 1,078(57.3) | 287(56.9) | 151(67.1) | |
| No preference | 69(2.6) | 54(2.9) | 9(1.8) | 6(2.7) | |
Note: The analysis was limited in parents who have not vaccinated their children. P-values were from Pearson Chi-square tests.